Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of …

Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Stock forecasts and analyst price target predictions for Catalyst Pharmaceuticals, Inc. (CPRX) stock, with detailed revenue and earnings estimates.

Nov 5, 2025 · Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 2025 total revenues of $148.4M, driven by FIRDAPSE, AGAMREE and FYCOMPA, and raised full‑year 2025 total revenue …

Feb 10, 2026 · Renewed interest in Catalyst Pharmaceuticals stock Renewed interest in Catalyst Pharmaceuticals (CPRX) stock has been driven by a mix of fundamental and technical factors, …

Science is our passion. Helping people live healthier, more productive lives is our reward. Explore our pipeline to view the clinical development programs. For more information about a program, please …